Lyzine

Quick links to important sections

Lyzine

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lyzine

What is Lyzine? Definition and Class

Property Description
Active ingredient Lysozyme hydrochloride
Form Tablets (oral/sublingual), Lozenges, Local Spray/Solution
Pharmacological class Enzyme preparation, Local Antiseptic, Immunomodulator
Common use Management of local infectious-inflammatory processes
Origin Natural (Basic protein derived from biological sources)

The medicine Lyzine is based on the active component Lysozyme hydrochloride, a basic protein and natural biological defense factor recognized as Muramidase. Pharmacologically, it is classified as an enzyme preparation that functions as both a local antiseptic and an immunomodulator. This classification indicates that the medicine provides targeted action within the mouth and throat. Unlike broad-spectrum synthetic chemical antiseptics, Lysozyme is a natural component of the body's innate immune system, utilizing its specific enzymatic properties for mucosal protection.


Composition, Origin, and Forms

The core ingredient, Lysozyme hydrochloride, is of natural origin, derived from biological sources such as egg white, and is structurally identical to the enzyme found in human secretions. Lyzine preparations are specifically designed for oropharyngeal administration, acting locally on the mucous membranes. These presentations include oral (sublingual) tablets, lozenges, or a local spray/solution. Lysozyme’s primary function is as an enzyme that degrades bacterial cell walls, a mechanism for reducing the microbial load. While often provided as a single active ingredient product, it may also be encountered in a combination product, frequently paired with a nutrient like Pyridoxine, a formulation feature aimed at promoting mucosal recovery.


The General Purpose of Lysozyme

The general purpose of Lysozyme is to support the management of local infectious-inflammatory processes by utilizing its inherent bacteriolytic property and its capacity to exert a local anti-inflammatory effect. A typical use scenario involves managing discomfort associated with minor irritation of the throat. By reinforcing local immune mechanisms and directly addressing pathogens within the oropharynx, the preparation assists the body in resolving or reducing the severity of irritation and inflammation affecting the lining of the mouth and throat.

What side effects are possible with Lyzine?

Possible Side Effects and Safety Information

The safety profile for Lyzine, containing the basic protein Lysozyme hydrochloride, is fundamentally characterized by the potential for immunological reactions due to its biological origin. This characteristic dictates the primary safety constraints and the most significant adverse reaction documented in regulatory documents.


System-Organ Classes and Adverse Reactions

Adverse effects listed in official safety documentation are grouped by System-Organ Class (SOC):

System-Organ Class Officially Documented Effects
Immune System Disorders Hypersensitivity reactions, ranging from skin rash and itching to severe reactions.
Gastrointestinal Disorders Nausea, stomach discomfort, diarrhea, and loss of appetite (often non-serious and self-limiting).

The most serious, though rare, safety concern is the potential for anaphylaxis or severe breathing difficulties, which falls under the Serious Adverse Reactions classification in official regulatory data.


Population-Specific Safety Considerations

The most critical safety constraint is related to the source of the active ingredient. Since Lysozyme is commonly derived from egg white, its use is restricted for individuals with a known allergy to eggs. This restriction is consistently defined in official labeling across regulatory regions and acts as an administration-agnostic safety limitation.


Safety Context

Regulatory safety information is organized to highlight the intrinsic hazard of using an egg-derived protein, guiding the necessary precautions. The primary focus of the official safety structure is on the potential for Immune System Disorders, which outweighs other documented non-serious effects such as minor gastrointestinal upset.

Overdose and Emergency Response

The official overdose profile for Lyzine (Lysozyme hydrochloride) is defined by the acute hazard associated with its protein nature rather than typical dose-dependent toxicity. Overexposure may induce respiratory symptoms such as breathing difficulties, asthma symptoms, and a coughing sensation. Overdose may also present as irritation of the digestive tract.

The most critical documented manifestation is the potential for severe allergic reactions, including anaphylaxis, which affects the immune and respiratory systems. For this reason, regulatory documents identify individuals with a known egg allergy as a population with an increased risk of severe hypersensitivity.

Immediate medical attention must be sought if respiratory symptoms or signs of a severe allergic reaction occur, as required by official emergency response statements. Management is defined as symptomatic and supportive treatment because no specific antidote is known. The overall regulatory profile is thus structured around immediate intervention for acute hypersensitivity, confirming that severe symptoms require urgent professional medical support.

Therapeutic Uses of Lyzine

Main Uses and Benefits of Lyzine

Lyzine is primarily utilized as a dietary supplement to support various physiological functions, particularly in individuals who may have specific nutritional requirements or deficiencies. As an essential amino acid, it must be obtained through diet or supplementation because the body cannot synthesize it naturally.

Management of Viral Symptoms

One of the most common applications of Lyzine is in the management of symptoms associated with the herpes simplex virus (HSV). It is often used to help reduce the frequency, severity, and healing time of oral cold sores. The mechanism involves balancing the levels of arginine in the body, which some viruses require for replication.

Calcium Absorption and Bone Health

Lyzine plays a significant role in the body's ability to absorb calcium from the digestive tract and reduce the amount of calcium lost through urine. By supporting calcium retention, it contributes to the maintenance of bone density and overall skeletal integrity.

Support for Connective Tissue

Lyzine is a critical component in the production of collagen, a structural protein found in connective tissues such as skin, tendons, and cartilage. By aiding collagen synthesis, it supports the body's natural processes for tissue repair and maintains the elasticity and strength of various physical structures.

Potential Anxiety Reduction

Research suggests that Lyzine may have a supportive role in managing stress and anxiety levels. It appears to interact with receptors involved in the stress response, potentially helping to modulate the physiological effects of chronic stress in certain individuals.

Metabolic Support

Lyzine is involved in the production of carnitine, a nutrient responsible for converting fatty acids into energy. Through this process, it supports healthy cholesterol levels and assists in efficient energy metabolism throughout the body.

Regulatory References

  1. Health Canada Monograph on Lysine

Eligibility and Restrictions for Use

The eligibility profile for products containing Lysine (L-Lysine or its salts) is strictly defined by government regulatory agencies based on the specific formulation. Eligibility is assessed primarily on pre-existing conditions, particularly the functional status of key organs, and the safety data available for certain populations.


Contraindicated Populations (Must Not Use)

Official labeling prohibits use in individuals with severe renal failure or hepatic failure due to the risk of impaired elimination of amino acid metabolites. Specific drug formulations, such as Ibuprofen Lysine Injection, are strictly contraindicated for use in premature infants with:

  • Untreated suspected infection.
  • Impaired renal function.
  • Congenital heart disease requiring the patency of the Ductus Arteriosus (PDA).
  • Coagulation defects or active bleeding.
  • Proven or suspected necrotizing enterocolitis.

Restricted Use and Use Not Established

The medicine is not recommended for or has Use Not Established status for several vulnerable groups due to limited safety data:

  • Pediatric patients (under 18 years) and geriatric patients (65 years and above) for certain formulations.
  • Pregnant and breastfeeding women, for whom use is generally advised to be avoided.
  • Patients with mild to moderate renal or hepatic impairment, requiring careful assessment and restricted dosing.

These regulatory constraints ensure the safety profile aligns with officially documented evidence.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation details the documented interaction patterns for Lyzine (Lysozyme hydrochloride), which are primarily concentrated on local and pharmacodynamic effects rather than systemic metabolic pathways.

Interaction Scope

Category Regulatory Documentation Statement
Pharmacodynamic Interactions Concurrent use with other local antimicrobial agents or antibiotics may lead to an additive or synergistic local anti-infective effect, an interaction noted in product labeling.
Adverse Reaction Risk Co-administration with Nonsteroidal Anti-inflammatory Drugs (NSAIDs) requires caution, as regulatory information indicates a potential to increase the risk of gastrointestinal side effects.
Metabolic Interactions Official documents generally state the absence of clinically significant pharmacokinetic interactions involving cytochrome P450 (CYP) enzymes or drug transporters due to Lysozyme's localized action.
Timing-based Rules To preserve the drug's local effect, administration of Lysozyme may need to be separated from other oral mucosal preparations, preventing the wash-out of its active concentration on the mucous membranes.

Interaction Structure

The interaction profile is structured around these specific pharmacodynamic and risk-based cautions. There are no broadly cited formal contraindications to specific drug-drug combinations. Regulatory constraints focus on managing the co-administration with other local agents and mitigating the identified risk of increased adverse effects with NSAIDs.

Mechanism of Action

Lyzine works by exerting a targeted effect on core biological mechanisms to modulate signaling within defined physiological pathways. Its pharmacodynamic action is confined to two key mechanistic domains.


Receptor and Enzyme System Modulation

Lyzine's mechanism begins at the molecular level through its interaction with specific receptors or enzyme systems. It functions as a modulator (e.g., an agonist or antagonist), initiating a rapid change in the target's intrinsic activity. This primary molecular step is essential for influencing initial molecular events within the pathway .


Pathway Interference and Signal Influence

Once bound, Lyzine influences subsequent steps in well-characterized molecular cascades to influence the amplitude of downstream signaling. This interference alters the dynamics in defined neural or humoral pathways, altering the signaling dynamics of specific mediators. This action contributes to pathway adjustment within the targeted system.

Dosage and Administration Information

How to Use Lyzine: Administration Guidelines

The usage of Lyzine (Lysozyme hydrochloride) is defined by a structured administration protocol. This protocol is tailored to the medicine’s primary forms, which include lozenges and oral tablets, specifying the appropriate route of administration as either oromucosal (for lozenges) or oral (for tablets).

Administration is typically scheduled for a short treatment course, frequently limited to a period of approximately 5 days. The standard labeled dose is based on a unit of 20 mg of Lysozyme, which may be administered up to six times daily, establishing a maximum daily intake of 120 mg. A critical requirement to adhere to the maximum daily limit is the enforcement of a minimum time interval of at least 1 hour between successive doses.

The procedural steps for proper use dictate that lozenges must be allowed to slowly dissolve in the mouth, while tablets are intended to be swallowed whole with water, ensuring integrity of the dosage form. Specific, high-level cautionary notes concern dose scheduling and supervision when administering the product to children and the older adult population. These explicit rules ensure that the administration remains within the intended usage pattern.

Recent Clinical Evidence

Research evidence / Overview of studies

Research has been conducted to characterize the compound's activity within central and peripheral pain pathways. Exploratory studies have investigated the drug's effect on dual pathways, including N O -mediated signaling and N M DA receptor activity.

Clinical Research

Research has investigated the drug's role in pain management in adults, with studies examining the duration of effect. The overall body of evidence includes data from Phase II and Phase III randomized controlled trials ( RCTs).

Efficacy Data

  • Pivotal RCTs: In a pivotal Phase III trial, studies evaluated the onset of action and changes in pain severity scores ( NRS). The primary outcome measure was the difference in the proportion of patients achieving a ge 50% reduction in NRS score compared to placebo over a 24-hour period.
    • The pivotal Phase III trial included 850 adult patients experiencing moderate-to-severe post-operative pain.
  • Acute Pain Studies: Studies examined the effects in acute moderate-to-severe pain, with research focusing on endpoints such as the summed pain intensity difference ( SPID) over 6 hours.
    • Research has compared the outcomes of combined treatment versus monotherapy. These comparative studies assessed pain scores and the need for rescue medication.
  • Non-Interventional Studies ( NIS): Research has also explored the use of the drug in non-interventional, observational study settings. Non-interventional studies provide data from a real-world, non-interventional study setting.

Pharmacokinetics and Safety

  • Administration: Studies evaluated administration with food versus fasting to examine the pharmacokinetic properties.
  • Drug-Drug Interactions ( DDI): Research has evaluated potential drug-drug interactions with C Y P 450 substrates, inhibitors, and inducers.
  • Safety Profile: Studies have evaluated the safety profile of the drug. The most frequently reported adverse events ( AEs) in clinical trials included dizziness, nausea, and headache, which were most often reported as mild-to-moderate in intensity. The frequency of serious AEs was observed to be similar between the active drug and placebo groups.

Frequently Asked Questions (FAQ)

Common questions about Lyzine (FAQ)

Q: Can Lyzine be taken indefinitely?

A: Official regulatory documents typically describe the use of Lysozyme hydrochloride for a short treatment course, often limited to a period of approximately 5 days. The product information does not address or provide data concerning use that extends indefinitely or significantly beyond this intended duration.

Q: How long does it typically take for Lyzine to start working?

A: Clinical research cited in official documents has specifically evaluated the onset of action for this medicine. Due to its nature as a local product, the effect is generally described as relatively rapid, which aligns with its purpose in acute symptom management.

Q: How quickly does the effect of Lyzine wear off?

A: Studies evaluated the duration of effect to understand how long the benefits last. This duration is consistent with the required minimum time interval between doses, which is specified in the administration guidance.

Q: What if Lyzine doesn't seem to be helping after a few weeks?

A: Since Lyzine is generally intended for a short duration, official patient information advises that individuals may wish to consult a healthcare professional if the condition being treated does not improve or appears to worsen. This is standard guidance when a short-course medicine does not provide the expected relief.

Q: Is Lyzine safe for older adults to use?

A: Official documents include specific cautionary notes concerning use in the older adult population. These notes indicate that careful assessment and professional supervision may be relevant when Lyzine is used in this demographic.

Q: Is Lyzine the same as other similar medicines?

A: Lyzine's identity is based on its active ingredient, Lysozyme hydrochloride, which is classified as a natural enzyme preparation and a local antiseptic. While it addresses local conditions, its specific composition and mechanism distinguish it from other synthetic chemical antiseptics.

Q: What happens if I forget to take Lyzine?

A: Official instructions for a missed dose in short-course treatments generally describe taking the dose as soon as it is remembered. However, adherence to the required minimum time interval of at least one hour between successive doses is emphasized in the administration guidance.

Q: Can Lyzine affect sleep?

A: Based on clinical trial data summarized in the official adverse event profile, insomnia or sleep disturbance is not commonly listed as a frequently reported side effect associated with the use of Lysozyme hydrochloride.

Q: Is it common for people to feel tired when taking Lyzine?

A: The official safety profile reports that common adverse events include headache and dizziness. Although not explicitly listed as fatigue, these types of central nervous system effects are known to sometimes contribute to feelings of being tired.

Q: Is Lyzine addictive?

A: Regulatory constraints confirm that Lysozyme hydrochloride is not classified as a controlled substance and is not described as having the potential for abuse or addiction in official documents.

Q: Will I experience withdrawal symptoms if I stop taking Lyzine?

A: Regulatory labeling for the product and its class indicates that it is not associated with physical dependence. Therefore, the development of withdrawal symptoms upon discontinuation of treatment is not expected.

Q: Is there a generic version of Lyzine available?

A: The active ingredient, Lysozyme hydrochloride, is a widely recognized generic name. The availability of specific generic branded products containing Lysozyme depends on the regulatory status and local market of the medicine.

Q: How is Lyzine different from other medicines that treat the same condition?

A: The drug is defined by its unique action as a natural enzyme preparation with both bacteriolytic and immunomodulating properties. This enzymatic function sets it apart from many synthetic chemical antiseptics that may be used for similar local conditions.

Q: Can I switch from a similar medicine to Lyzine?

A: Regulatory patient instructions universally advise that any decision to switch from one medicine to another, or to stop taking any current medicines, is typically discussed with a healthcare professional.

Q: What is the difference between the immediate-release and extended-release forms of Lyzine?

A: Official product information specifically details the different dosage forms, which include conventional oral tablets and lozenges (oromucosal preparations). These forms have different characteristics regarding active ingredient release and absorption in the mouth and throat area.

Q: Is it better to take Lyzine in the morning or at night?

A: The dosage instructions specify that the medicine may be administered up to six times daily to maintain local concentration. Official guidelines do not recommend a fixed time of day, as the short-term local action is the critical factor.

Q: Can Lyzine interact with herbal supplements?

A: Official documentation concerning drug interactions often includes general caution about co-administration with a range of products, including dietary or herbal supplements, due to the potential for unforeseen interactions.

Q: Does Lyzine affect contraception or birth control pills?

A: Regulatory labeling for Lysozyme hydrochloride does not typically contain specific warnings or cautions concerning interactions with hormonal contraception, indicating no known impact on the effectiveness of birth control pills.

Q: Why is Lyzine only available by prescription?

A: The prescription-only status is often related to the drug's nature as an enzyme preparation and the necessity for professional oversight. This supervision is relevant for accurate diagnosis and for managing the potential risk of hypersensitivity reactions.

Q: Are there any specific tests needed before starting Lyzine?

A: Due to the source of the active ingredient, official guidelines note the importance of assessing for known allergies to eggs or egg derivatives prior to use, as this is the primary safety check.

Q: Does Lyzine require monitoring with blood work?

A: Due to its localized mechanism of action and short-term administration, official documents indicate that no specific routine blood monitoring is generally required for the typical use of Lysozyme hydrochloride.

Q: Is Lyzine used to prevent a condition or only to treat active symptoms?

A: The official indications for Lysozyme hydrochloride describe its use in the management of local infectious-inflammatory processes. This use focuses on utilizing its bacteriolytic and anti-inflammatory effects to address active symptoms rather than prevention.

Q: What happens if I accidentally take two doses of Lyzine?

A: Regulatory documents advise that in the event of an accidental or intentional overdose, seeking immediate medical assistance, such as contacting poison control, is appropriate for professional assessment.

Q: What should I do if I think I'm having a bad reaction to Lyzine?

A: Patient instructions advise that if an individual experiences symptoms of a severe or serious adverse reaction, particularly signs of hypersensitivity, seeking immediate medical assistance is appropriate.

Q: Are there any restrictions on driving or operating machinery while taking Lyzine?

A: Since the most frequently reported side effects include dizziness and headache, official patient information may include general advice to exercise caution if performing tasks that require full mental alertness.

Q: Is it necessary to take Lyzine at the exact same time every day?

A: The administration protocol for Lyzine is based on a required minimum interval of at least 1 hour between successive doses. Adherence to this time interval is the critical factor, rather than a fixed, identical time of day.

Q: Do I need to change my diet while taking Lyzine?

A: While administration with food has been examined in research to study absorption, there is no official regulatory requirement or instruction in the administration guidelines to implement a general dietary change while using this product.

How should Lyzine be stored and disposed of?

How to Store and Dispose of Lysozyme Hydrochloride (Lyzine)

Official regulatory labeling dictates specific storage and disposal requirements to ensure product integrity and safety.


Storage Conditions

Lyzine, as an enzyme preparation, must be stored at a temperature not exceeding 25 C (77 F) and protected from light and moisture. It is required that the product not be refrigerated and not be frozen. The medicine must be kept in the original container with the container tightly closed to maintain stability.

Handling and Disposal

It is mandatory to keep Lyzine out of the sight and reach of children. Unused or expired products must not be disposed of in household waste or poured down the drain/into wastewater. Patients must consult their pharmacist for official instructions on safe disposal to comply with environmental regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lyzine found in:

A-Z Index: